Thickness of malignant melanoma: global analysis of related factors.

[1]  R. Paladugu,et al.  Acral lentiginous melanoma A clinicopathologic study of 36 patients , 2006, Cancer.

[2]  A. Kopf,et al.  Prognostic significance of hypopigmentation in malignant melanoma. , 1987, Archives of dermatology.

[3]  J. B. Howell.  Spotting sinister spots. A challenge to dermatologists to examine every new patient at increased risk for signs of early melanoma. , 1986, Journal of the American Academy of Dermatology.

[4]  A. Kopf,et al.  Relationship of lumbosacral nevocytic nevi to sun exposure in dysplastic nevus syndrome. , 1986, Archives of dermatology.

[5]  A. Sober,et al.  Does wide excision as the initial diagnostic procedure improve prognosis in patients with cutaneous melanoma? , 1986, The Journal of dermatologic surgery and oncology.

[6]  A. Steiner,et al.  Late metastases of cutaneous malignant melanoma , 1986, The British journal of dermatology.

[7]  J. V. Von Roenn,et al.  Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. , 1986, Cancer research.

[8]  L. Schnipper,et al.  Clinical implications of tumor-cell heterogeneity. , 1986, The New England journal of medicine.

[9]  M. Nap,et al.  Comparison of two methods of treating primary malignant melanomas clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion , 1986, Cancer.

[10]  W. Clark,et al.  The biologic forms of malignant melanoma. , 1986, Human pathology.

[11]  D. Lawrence,et al.  Pretreatment effects on the uptake/retention kinetics of L-dopa in Harding-Passey melanoma. , 1986, The Journal of investigative dermatology.

[12]  M. Mihm,et al.  Prognosis for polypoidal melanoma is determined by primary tumor thickness , 1986, Cancer.

[13]  P. Nowell,et al.  A t(1;19) chromosome translocation in three cases of human malignant melanoma. , 1986, Cancer research.

[14]  C. Taylor,et al.  Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections. , 1986, The Journal of investigative dermatology.

[15]  Evans Jf,et al.  Malignant melanoma and its precursors: The growing need for early identification , 1986 .

[16]  J. Bennett,et al.  Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.

[17]  N. Wright,et al.  Are there differences in the cell cycle of normal and malignant cells? An approach to the analysis of the clonal expansion of cells in malignant epithelial proliferations in situ. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[18]  A. Cochran,et al.  Recurrence potential of thin primary melanomas , 1986, Cancer.

[19]  L. Gordon,et al.  The incidence and pathogenesis of invasive cutaneous malignant melanoma in Northern Ireland. , 1986, British Journal of Cancer.

[20]  N. Penneys.  Excision of melanoma after initial biopsy , 1985 .

[21]  A. Swerdlow.  Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford Region. , 1985, British Journal of Cancer.

[22]  J. Spinelli,et al.  Rethinking recycling. , 1995, Environmental health perspectives.

[23]  A. Sober,et al.  Does biopsy type influence survival in clinical stage I cutaneous melanoma? , 1985, Journal of the American Academy of Dermatology.

[24]  V. Hearing,et al.  Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes. , 1985, The Journal of investigative dermatology.

[25]  M. S. Blois,et al.  Regression in malignant melanoma. A histologic feature without independent prognostic significance , 1985, Cancer.

[26]  F. Rampen,et al.  Punch biopsy of melanoma. , 1985, Journal of the American Academy of Dermatology.

[27]  D. West,et al.  An inquiry into the epidemiology of melanoma. , 1985, American journal of epidemiology.

[28]  R. Silverman,et al.  A histologic comparison of congenital and acquired nevomelanocytic nevi. , 1985, Archives of dermatology.

[29]  D. Ellis,et al.  Estrogen and progesterone receptors in melanocytic lesions. Occurrence in patients with dysplastic nevus syndrome. , 1985, Archives of dermatology.

[30]  S. Ferrone,et al.  Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues. , 1985, The Journal of investigative dermatology.

[31]  M. Melamed,et al.  Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.

[32]  H. Wanebo,et al.  Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. , 1985, Archives of dermatology.

[33]  J. J. Chanda,et al.  Adverse effect of melanoma incision. , 1985, Journal of the American Academy of Dermatology.

[34]  Giltman Li,et al.  Elective lymph node dissection in stage I melanoma-necessary or not? , 1985 .

[35]  J. Fraser,et al.  Migration and death from malignant melanoma , 1985, International journal of cancer.

[36]  W. McCarthy,et al.  SUBUNGUAL MALIGNANT MELANOMA: A DISEASE ENTITY SEPARATE FROM OTHER FORMS OF CUTANEOUS MELANOMA , 1985, The Australasian journal of dermatology.

[37]  G. G. Caldwell,et al.  Life-Style Factors Among Patients With Melanoma , 1985, Southern medical journal.

[38]  W. Clark,et al.  The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51—3.99 mm) , 1985, Cancer.

[39]  D J Ruiter,et al.  Phenotypic dynamics of tumor progression in human malignant melanoma , 1985, International journal of cancer.

[40]  T. Cole.  Melanoma of the head and neck , 1985 .

[41]  D. Ruiter,et al.  Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi. , 1985, The Journal of investigative dermatology.

[42]  A. Kochar.  Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. , 1985, The American journal of medicine.

[43]  S. Ferrone,et al.  Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. , 1985, Journal of immunology.

[44]  M. Mihm,et al.  Capsule dermatopathology: clinicopathologic types of malignant melanoma--relevance to biologic behavior and diagnostic surgical approach. , 1985, The Journal of dermatologic surgery and oncology.

[45]  M. S. Blois,et al.  Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. , 1985, Annals of surgery.

[46]  F. Rampen,et al.  Levodopa and melanoma: three cases and review of literature. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[47]  T. Weeramanthri,et al.  Surgical treatment and survival from cutaneous malignant melanoma. , 1985, The Australian and New Zealand journal of surgery.

[48]  W. McCarthy,et al.  Resection margins for melanoma. , 1985, Australian and New Zealand Journal of Surgery.

[49]  R. Abe,et al.  Subungual melanoma. A clinicopathologic study of 16 Japanese cases , 1985, Cancer.

[50]  R. MacKie,et al.  Malignant melanocytic tumours , 1985, Journal of cutaneous pathology.

[51]  A. Kopf,et al.  Prevalence of congenital-nevus-like nevi, nevi spili, and café au lait spots. , 1985, Archives of dermatology.

[52]  J. Tobacman.  Do malignant melanoma cells arise from the hair follicle? , 1985, The British journal of dermatology.

[53]  P. Duray,et al.  Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma. , 1985, The Journal of investigative dermatology.

[54]  R. Dillman,et al.  Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. , 1985, Radiology.

[55]  D. Rigel,et al.  Prognosis of malignant melanoma. , 1985, Dermatologic clinics.

[56]  M. Greene,et al.  Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. , 1985, Dermatologic clinics.

[57]  H. Wanebo,et al.  Thin (<1 mm) Melanomas of the Extremities Are Biologically Favorable Lesions Not Influenced by Regression , 1985 .

[58]  W. Clark,et al.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.

[59]  A. Kopf,et al.  Precursors of malignant melanoma. Problems in computing the risk of malignant melanoma arising in dysplastic and congenital nevocytic nevi. , 1985, Dermatologic clinics.

[60]  J. Elwood,et al.  Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study. , 1985, British Journal of Cancer.

[61]  A. Kopf,et al.  Prevention of malignant melanoma. , 1985, Dermatologic clinics.

[62]  A. Kopf,et al.  Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome. , 1985, Journal of the American Academy of Dermatology.

[63]  R. Klevecz,et al.  Cell‐cycle‐dependent expression of human melanoma membrane antigen analyzed by flow cytometry , 1985, Cancer.

[64]  C. Balch,et al.  The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma , 1985, Cancer.

[65]  H. Bear,et al.  Prognosis of level V malignant melanoma , 1985, Cancer.

[66]  V. Siskind,et al.  Common acquired naevi and the risk of malignant melanoma , 1985, International journal of cancer.

[67]  G. Currie,et al.  Activation of N-ras in a human melanoma cell line , 1985, Molecular and cellular biology.

[68]  G. Spears,et al.  Frequency of moles in a defined population. , 1985, Journal of epidemiology and community health.

[69]  W. Greco,et al.  Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical stage I , 1985, Cancer.

[70]  L. Hughes,et al.  A policy of selective excision for primary cutaneous malignant melanoma. , 1985, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[71]  R. Lew,et al.  Malignant melanoma prognostic factors 7: elective lymph node dissection. , 1985, The Journal of dermatologic surgery and oncology.

[72]  V. Siskind,et al.  Sunburn and malignant melanoma. , 1985, British Journal of Cancer.

[73]  D. Laube,et al.  A histopathologic evaluation of nevocellular nevi in pregnancy. , 1985, Archives of dermatology.

[74]  J. Johnson,et al.  In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89 , 1985, The Journal of experimental medicine.

[75]  F. Rampen,et al.  Biopsy and survival of malignant melanoma. , 1985, Journal of the American Academy of Dermatology.

[76]  W. Clark,et al.  Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. , 1985, The New England journal of medicine.

[77]  M. S. Blois,et al.  The Frequency of Local Recurrence and Microsatellites as a Guide to Reexcision Margins for Cutaneous Malignant Melanoma , 1984, Annals of surgery.

[78]  A. Green.  Sun exposure and the risk of melanoma. , 1984, The Australasian journal of dermatology.

[79]  C. Balch,et al.  Head and Neck Melanoma in 534 Clinical Stage I Patients: A Prognostic Factors Analysis and Results of Surgical Treatment , 1984, Annals of surgery.

[80]  K. Westbrook,et al.  Melanoma today does not require radical surgery. , 1984, American journal of surgery.

[81]  T. Fitzpatrick,et al.  Skin markings in the diagnosis and prognosis of cutaneous melanoma. , 1984, Archives of dermatology.

[82]  A. Kopf,et al.  Prognosis in Stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[83]  B. Armstrong,et al.  Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. , 1984, British Journal of Cancer.

[84]  K. Foon,et al.  Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  R. Griffiths,et al.  Experience of thin cutaneous melanomas (< 0.76 mm and < 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up , 1984 .

[86]  R. Stern,et al.  Sun and malignant melanoma. , 1984, Journal of the American Academy of Dermatology.

[87]  J. Hunter,et al.  Primary management of melanoma , 1984, The British journal of dermatology.

[88]  R. Griffiths,et al.  A study of the thickness of uninvolved dermis beneath cutaneous malignant melanoma: the ratio of uninvolved dermis to tumour thickness (DT:TT) as a prognostic index. , 1984, British journal of plastic surgery.

[89]  J. Kirkwood,et al.  Vitiligo and melanoma: can genetically abnormal melanocytes result in both vitiligo and melanoma within a single family? , 1984, Journal of the American Academy of Dermatology.

[90]  R. Griffiths,et al.  Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death. , 1984, British journal of plastic surgery.

[91]  M. S. Blois,et al.  Lentigo maligna melanoma has no better prognosis than other types of melanoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  D. Ruiter,et al.  Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. , 1984, Cancer Research.

[93]  F. Rampen.  Sex Differences in Survival from Cutaneous Melanoma , 1984, International journal of dermatology.

[94]  A. Cochran,et al.  Occult melanoma in lymph nodes detected by antiserum to S‐100 protein , 1984, International journal of cancer.

[95]  M. Taniguchi,et al.  Syngeneic monoclonal antibodies against melanoma antigens with species specificity and interspecies cross-reactivity. , 1984, The Journal of investigative dermatology.

[96]  O. Braun-falco,et al.  Prognostic classification of malignant melanoma by clinical criteria , 1984, The British journal of dermatology.

[97]  C. J. O'doherty,et al.  BENIGN NAEVI ASSOCIATED WITH HIGH RISK OF MELANOMA , 1984, The Lancet.

[98]  M. Goldschmidt.  Sebaceous and hepatoid gland neoplasms of dogs and cats. , 1984, The American Journal of dermatopathology.

[99]  M. Rosin,et al.  Malignant melanoma and levodopa. , 1984, Cutis.

[100]  J. Majeski,et al.  Ability of cancer patients' macrophages to kill autologous tumor targets: Effect of prostaglandin inhibitors on cytotoxicity , 1984, Cancer.

[101]  W. Clark,et al.  Preoperative nuclear scans in patients with melanoma , 1984, Cancer.

[102]  J Hiss,et al.  Preoperative ultrasonic measurements of the thickness of cutaneous malignant melanoma. , 1984, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[103]  J. Vaughan.  Rheumatoid arthritis: evidence for a defect in T-cell function. , 1984, Hospital practice.

[104]  P. Bozzo,et al.  Chronic solar ultraviolet damage associated with malignant melanoma of the skin. , 1984, Journal of the American Academy of Dermatology.

[105]  T. Fitzpatrick,et al.  Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. , 1984, JAMA.

[106]  D. Ruiter,et al.  Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma , 1984, Cancer.

[107]  I. Campbell,et al.  Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. , 1984, Journal of clinical pathology.

[108]  Ackerman Ab,et al.  The effects of resin of podophyllin on condyloma acuminatum. , 1984 .

[109]  P. Nowell,et al.  Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.

[110]  M. Mihm,et al.  Conservative surgical management of superficially invasive cutaneous melanoma , 1984, Cancer.

[111]  A. Houghton,et al.  Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation. , 1984, The American journal of pathology.

[112]  E. Bröcker,et al.  HLA-DR antigen expression in primary melanomas of the skin. , 1984, The Journal of investigative dermatology.

[113]  V. Beral,et al.  REPRODUCTIVE HISTORIES IN DIABETIC WOMEN WITH LATER DEVELOPING FURTHER ENDOCRINE DISEASE , 1984, The Lancet.

[114]  C. Ellis,et al.  An evaluation of vertical growth in thin superficial spreading melanomas by sequential serial microscopic sections , 1983, Cancer.

[115]  A. Aguzzi,et al.  The impact of monoclonal antibodies on the study of human malignant melanoma , 1983, Journal of cutaneous pathology.

[116]  D. Reintgen,et al.  Cutaneous melanoma of the head and neck. A review of 399 cases. , 1983, Archives of otolaryngology.

[117]  N. Cook,et al.  Sun exposure habits in patients with cutaneous melanoma: a case control study. , 1983, The Journal of dermatologic surgery and oncology.

[118]  R. Gaynor,et al.  S‐100Protein: A Marker for Melanocytic Tumors a , 1983 .

[119]  M. Meregalli,et al.  The prognostic value of T‐lymphocyte levels in malignant melanoma. A five‐year follow‐up , 1983, Cancer.

[120]  J. Kirkwood,et al.  Vitiligo in patients with metastatic melanoma: a good prognostic sign. , 1983, Journal of the American Academy of Dermatology.

[121]  S J Soong,et al.  Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia , 1983, Cancer.

[122]  M. Mihm,et al.  Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study. , 1983, Journal of the American Academy of Dermatology.

[123]  W. Clark,et al.  Phenotypic characteristics of cells derived from precursors of human melanoma. , 1983, Cancer research.

[124]  W. Birchmeier,et al.  Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[125]  M. Levenstein,et al.  Relationship of fluorescent lights to malignant melanoma: another view. , 1983, The Journal of dermatologic surgery and oncology.

[126]  N. Cascinelli,et al.  Metastatic Spread of Stage I Melanoma of the Skin , 1983, Tumori.

[127]  M. S. Blois,et al.  Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival , 1983, Cancer.

[128]  H. Wiebelt,et al.  Prognostic groups of patients with stage I melanoma. , 1983, Archives of dermatology.

[129]  R. Lew,et al.  Malignant melanoma prognostic factors 3: surgical margins. , 1983, The Journal of dermatologic surgery and oncology.

[130]  S. Weiss,et al.  Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[131]  D. Reintgen,et al.  Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. , 1983, Annals of surgery.

[132]  A. Ackerman,et al.  How wide and deep is wide and deep enough? A critique of surgical practice in excisions of primary cutaneous malignant melanoma. , 1983, Human pathology.

[133]  C. Holman,et al.  Survival from preinvasive and invasive malignant melanoma in Western Australias , 1983, Cancer.

[134]  M. S. Blois,et al.  Judging Prognosis in Malignant Melanoma of the Skin: A Problem of Inference over Small Data Sets , 1983, Annals of surgery.

[135]  K. Kraemer.  Dysplastic nevi as precursors to hereditary melanoma. , 1983, The Journal of dermatologic surgery and oncology.

[136]  G. Steinbach,et al.  Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma‐associated antigens , 1983, Journal of cutaneous pathology.

[137]  A. Kopf,et al.  Effect of anatomical location on prognosis in patients with clinical stage I melanoma. , 1983, Archives of dermatology.

[138]  V. Beral,et al.  Cutaneous factors related to the risk of malignant melanoma , 1983, The British journal of dermatology.

[139]  W. Clark,et al.  Skin markings in malignant melanoma. , 1983, JAMA.

[140]  B. Pasternack,et al.  STATISTICS, T-LYMPHOCYTE SUBPOPULATIONS, AND HAEMOPHILIA , 1983, The Lancet.

[141]  G. Hutchins,et al.  Patterned distribution of metastases from malignant melanoma in humans. , 1983, Cancer research.

[142]  W. Rehpenning,et al.  [Potentials and limits of ultrasonic diagnosis for the in vivo determination of the depth of invasion of malignant melanoma]. , 1983, Zeitschrift fur Hautkrankheiten.

[143]  A. Kopf,et al.  Local and In‐Transit Metastases Following Definitive Excision for Primary Cutaneous Malignant Melanoma , 1983, Annals of surgery.

[144]  E. Creagan,et al.  Metastasis and Death in Patients with Thin Melanomas (Less than 0.76 mm) , 1983, Annals of surgery.

[145]  C. Beattie,et al.  Late recurrence of cutaneous melanoma. , 1983, Archives of surgery.

[146]  J. Elwood,et al.  Site distribution of malignant melanoma. , 1983, Canadian Medical Association journal.

[147]  M. Mihm,et al.  Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. , 1983, Journal of Investigative Dermatology.

[148]  J. Maize.  Primary cutaneous malignant melanoma. , 1983, Journal of the American Academy of Dermatology.

[149]  V. Le Doussal,et al.  Prognostic index for clinical Stage I cutaneous malignant melanoma. , 1983, Cancer research.

[150]  M. Mihm,et al.  Early death from clinical stage I melanoma. , 1983, The Journal of investigative dermatology.

[151]  A. Kopf,et al.  Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. , 1983, Archives of dermatology.

[152]  V. Camp,et al.  Evaluation of transsphenoidal hypophysectomy in the management of patients with advanced malignant melanoma , 1983, Cancer.

[153]  F. Rampen,et al.  MELANOMA HISTOGENESIS REVISITED , 1983, The Journal of dermatology.

[154]  Y. Adam,et al.  Cutaneous malignant melanoma: current views on pathogenesis, diagnosis, and surgical management. , 1983, Surgery.

[155]  A. Giuliano,et al.  LDH and melanoma , 1983, Cancer.

[156]  M C Mihm,et al.  Multivariate analysis. Some guidelines for physicians. , 1983, JAMA.

[157]  O. Braun-falco,et al.  Low- and high-risk malignant melanoma--III. Prognostic significance of the resection margin. , 1983, European journal of cancer & clinical oncology.

[158]  Harwood Ar.  Melanomas of the head and neck. , 1983 .

[159]  A. Kopf,et al.  Metastases of thin melanomas , 1983, Cancer.

[160]  S. Larson,et al.  Imaging of melanoma with L-131-labeled monoclonal antibodies. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[161]  W. Clark,et al.  Optimal Resection Margin for Cutaneous Malignant Melanoma , 1983, Plastic and reconstructive surgery.

[162]  P. Royston,et al.  Prognostic value of tumour thickness in cutaneous malignant melanoma , 1983, Journal of clinical pathology.

[163]  D. N. Papachristou,et al.  Melanoma arising under the nail , 1982, Journal of surgical oncology.

[164]  C. Balch,et al.  A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia , 1982, Annals of surgery.

[165]  R. MacKie,et al.  Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. , 1982, British Journal of Cancer.

[166]  J. Stilwell,et al.  The Histogenesis of malignant melanoma in relation to pre‐existing pigmented lesions , 1982, Journal of cutaneous pathology.

[167]  L. Old,et al.  Human melanoma antigen AH is an autoantigenic ganglioside related to GD2 , 1982, The Journal of experimental medicine.

[168]  J. Folkman,et al.  ANGIOGENESIS: INITIATION AND CONTROL * , 1982, Annals of the New York Academy of Sciences.

[169]  G Poste,et al.  Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[170]  C. Holman,et al.  A histological comparison of cutaneous malignant melanoma between the Oxford Region and Western Australia , 1982, Histopathology.

[171]  D. Reintgen,et al.  Malignant melanoma in black American and white American populations. A comparative review. , 1982, JAMA.

[172]  R. Griffiths,et al.  Simple and effective method of removing starch powder from surgical gloves , 1982, British medical journal.

[173]  M. Mihm,et al.  Classification of malignant melanomas according to the histologic morphology of melanoma nodules. , 1982, The Journal of dermatologic surgery and oncology.

[174]  A. Ackerman,et al.  A critique of techniques for biopsy of clinically suspected malignant melanomas , 1982, The American Journal of dermatopathology.

[175]  W. Clark,et al.  Melanoma classification: a testable hypothesis. , 1982, The American Journal of dermatopathology.

[176]  A. Ackerman.  Disagreements about classification of malignant melanomas. , 1982, The American Journal of dermatopathology.

[177]  L. Lieblich.  Classification of malignant melanomas: a view of the current controversy. , 1982, The American Journal of dermatopathology.

[178]  T. Nakajima,et al.  Immunohistochemical demonstration of S 100 protein in malignant melanoma and pigmented nevus, and its diagnostic application , 1982, Cancer.

[179]  A. Kopf,et al.  "Small" melanomas: relation of prognostic variables to diameter of primary superficial spreading melanomas. , 1982, The Journal of dermatologic surgery and oncology.

[180]  M. Mihm,et al.  Erythema in the primary lesion of superficial spreading melanoma is not of prognostic importance , 1982, The British journal of dermatology.

[181]  J. Bubis,et al.  The thin malignant melanoma. Changing patterns of epidemiology and treatment , 1982, Cancer.

[182]  V. Beral,et al.  MALIGNANT MELANOMA AND EXPOSURE TO FLUORESCENT LIGHTING AT WORK , 1982, The Lancet.

[183]  A. Giuliano,et al.  Results of Ilioinguinal Dissection for Stage II Melanoma , 1982, Annals of surgery.

[184]  G. Nicolson.  Cell surfaces and cancer metastasis. , 1982, Hospital practice.

[185]  J E Talmadge,et al.  Evidence for the clonal origin of spontaneous metastases. , 1982, Science.

[186]  J. Dooley,et al.  α1-ANTITRYPSIN DEFICIENCY AND LIVER DISEASE , 1982, The Lancet.

[187]  V. McGovern,et al.  Ulceration and prognosis in cutaneous malignant melanoma , 1982, Histopathology.

[188]  C. Putman,et al.  The efficacy of full-lung tomography in the detection of early metastatic disease from melanoma. , 1982, Radiology.

[189]  N. Dubin,et al.  Primary melanoma thickness correlated with regional lymph node metastases. , 1982 .

[190]  R. Elashoff,et al.  Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. , 1982 .

[191]  I. Fidler,et al.  Cancer metastasis is selective or random depending on the parent tumour population , 1982, Nature.

[192]  K. Drzewiecki,et al.  Survival with malignant melanoma: A regression analysis of prognostic factors , 1982, Cancer.

[193]  J. J. Thompson,et al.  Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. , 1982, The American journal of pathology.

[194]  N. Cascinelli,et al.  Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities , 1982, Cancer.

[195]  A. Bartolucci,et al.  Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience , 1982, Cancer.

[196]  W. Coleman,et al.  Acral Lentiginous Melanoma: A Clinicopathologic Entity , 1982, Annals of surgery.

[197]  A. Louie,et al.  Metastases in malignant melanoma. , 1982, The Australian and New Zealand journal of surgery.

[198]  V. McGovern.  The nature of melanoma. A critical review , 1982, Journal of cutaneous pathology.

[199]  I. Ariel.  Malignant melanoma of the trunk: A Retrospective review of 1128 patiens , 1982, Cancer.

[200]  M. Mihm,et al.  Narrower margins for clinical stage I malignant melanoma. , 1982, The New England journal of medicine.

[201]  C. Balch,et al.  Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients , 1982, The British journal of surgery.

[202]  M. Mihm,et al.  The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas. , 1982, Journal of the American Academy of Dermatology.

[203]  R. Wollmann,et al.  S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. , 1982, The American journal of pathology.

[204]  R. Reisfeld,et al.  Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[205]  J. Melski,et al.  Small congenital nevocellular nevi and the risk of cutaneous melanoma. , 1982, The Journal of pediatrics.

[206]  D. Crowther,et al.  The “Hot spleen” phenomenon in metastatic malignant melanoma. Its incidence and relationship with the immune system , 1982, Cancer.

[207]  R. Erlandson,et al.  Electron microscopy of a nevus cell aggregate associated with an axillary lymph node , 1982, Cancer.

[208]  M. Mihm,et al.  Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis , 1982 .

[209]  M. Mihm,et al.  Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions , 1982, Annals of surgery.

[210]  V. Beral,et al.  THE RELATIONSHIP OF MALIGNANT MELANOMA , BASAL AND SQUAMOUS SKIN CANCERS TO INDOOR AND OUTDOOR WORK , 2007 .

[211]  A. Houghton,et al.  Solar radiation and malignant melanoma of the skin. , 1981, Journal of the American Academy of Dermatology.

[212]  D. Sullivan,et al.  Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid. , 1981, AJR. American journal of roentgenology.

[213]  N. Cascinelli,et al.  Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics , 1981, Cancer.

[214]  J. Woods,et al.  Regional lymph node management and outcome in 100 patients with head and neck melanoma. , 1981, American journal of surgery.

[215]  R. K. Knight,et al.  Corticosteroids for elderly patients with breast cancer , 1981, Cancer.

[216]  M. Mihm,et al.  A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. , 1981, American journal of surgery.

[217]  M. Mihm,et al.  Malignant Melanoma: Prognostic Significance of “Microscopic Satellites” in the Reticular Dermis and Subcutaneous Fat , 1981, Annals of surgery.

[218]  R. Priore,et al.  A genetic analysis of melanoma--polygenic inheritance as a threshold trait. , 1981, American journal of epidemiology.

[219]  N. H. Wright,et al.  A case-control study of the possible association between oral contraceptives and malignant melanoma. , 1981, British Journal of Cancer.

[220]  M. Mihm,et al.  Nonepidermal Origin of Malignant Melanoma Associated with a Giant Congenital Nevocellular Nevus , 1981, Plastic and reconstructive surgery.

[221]  N. Dubin,et al.  Regional lymph node dissection for malignant melanoma of the extremities. , 1981, Surgery.

[222]  Manci Ea,et al.  Polypoid melanoma, a virulent variant of the nodular growth pattern. , 1981 .

[223]  P. Gill,et al.  Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours. , 1981, British Journal of Cancer.

[224]  B. Weber,et al.  Malignant melanoma: a search for occult lymph node metastases. , 1981, Human pathology.

[225]  M. Mihm,et al.  A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. , 1981, Surgery.

[226]  M. Mihm,et al.  A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease , 1981, Annals of surgery.

[227]  M C Mihm,et al.  Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes , 1981, Cancer.

[228]  D. Roses,et al.  Surgical management for malignant melanoma of the trunk. , 1981, Archives of surgery.

[229]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II) , 1981, Annals of surgery.

[230]  L. Humphrey.  Prophylactic lymph node dissection for malignant melanoma. When, why and by whom? , 1981, American journal of surgery.

[231]  R. Lotan,et al.  CHARACTERIZATION OF RETINOIC ACID‐INDUCED ALTERATIONS IN THE PROLIFERATION AND DIFFERENTIATION OF A MURINE AND A HUMAN MELANOMA CELL LINE IN CULTURE * , 1981, Annals of the New York Academy of Sciences.

[232]  D. Crowther,et al.  Malignant melanoma in children and adolescents , 1981, Cancer.

[233]  V. McGovern,et al.  Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival , 1980, Cancer.

[234]  Institut Gustave Roussy,et al.  Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma , 1980, International journal of cancer.

[235]  Goldman Li.  Decision in the management of cutaneous malignant melanoma. , 1980 .

[236]  C. Balch.  Surgical management of regional lymph nodes in cutaneous melanoma. , 1980, Journal of the American Academy of Dermatology.

[237]  D. Roses,et al.  Selective surgical management of cutaneous melanoma of the head and neck. , 1980, Annals of surgery.

[238]  A. Ackerman.  Malignant melanoma: a unifying concept. , 1980, Human pathology.

[239]  I. Ariel.  Malignant melanoma of the lower extremity: Evaluation of 453 patients , 1980, Journal of surgical oncology.

[240]  D. Lubahn,et al.  Sex steroid receptor analysis in human melanoma , 1980, Cancer.

[241]  N. Shiffman,et al.  Acral lentiginous melanoma. , 1980, Annals of plastic surgery.

[242]  E. Dvir,et al.  Measurement of Tumor Thickness As a Prognostic Tool in Primary Malignant Melanoma of the Skin , 1980, Annals of plastic surgery.

[243]  F. Rampen,et al.  Incisional procedures and prognosis in malignant melanoma , 1980, Clinical and experimental dermatology.

[244]  W. McCarthy,et al.  Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I) , 1980, The British journal of surgery.

[245]  A. Houghton,et al.  Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[246]  C. Balch,et al.  The prognostic significance of ulceration of cutaneous melanoma , 1980, Cancer.

[247]  M S Blois,et al.  Clinical characteristics of early cutaneous melanoma , 1980, Cancer.

[248]  V. McGovern,et al.  Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? , 1980, Histopathology.

[249]  V. McGovern,et al.  Histologic features of tumors and the female superiority in survival from malignant melanoma , 1980, Cancer.

[250]  B. Armstrong,et al.  Epidemiology of pre‐invasive and invasive malignant melanoma in Western Australia , 1980, International journal of cancer.

[251]  M C Mihm,et al.  Primary melanoma of the skin: recognition and management. , 1980, Journal of the American Academy of Dermatology.

[252]  R. Lew,et al.  The significance of augmented radiocolloid uptake by the spleen in patients with malignant melanoma. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[253]  M. Kripke,et al.  Speculations on the role of ultraviolet radiation in the development of malignant melanoma. , 1979, Journal of the National Cancer Institute.

[254]  V. McGovern,et al.  Prognostic significance of the histological features of malignant melanoma , 1979, Histopathology.

[255]  M. S. Blois,et al.  The thorax as the initial site for systemic relapse in malignant melanoma. A prospective survey of 324 patients , 1979, Cancer.

[256]  I. Crombie.  Racial differences in melanoma incidence. , 1979, British Journal of Cancer.

[257]  J. Kirkwood,et al.  Effects of oral contraceptives and pregnancy on melanomas. , 1979, The New England journal of medicine.

[258]  J. Brown,et al.  Cell surface antigens of human melanoma identified by monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[259]  O. Klepp,et al.  Some environmental and bodily characteristics of melanoma patients. A case‐control study , 1979, International journal of cancer.

[260]  W. N. Tauxe,et al.  Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. , 1979, Radiology.

[261]  G. Todaro,et al.  Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[262]  C. Balch,et al.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients , 1979, Cancer.

[263]  T. Smith.  The Queensland Melanoma Project--an exercise in health education. , 1979, British medical journal.

[264]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark's and Breslow's Staging Methods , 1978, Annals of surgery.

[265]  L. S. Graham,et al.  The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. , 1978, Surgery.

[266]  M. S. Blois,et al.  The regressing thin malignant melanoma. A distinctive lesion with metastatic potential , 1978, Cancer.

[267]  N. Davis.  Modern concepts of melanoma and its management. , 1978, Annals of plastic surgery.

[268]  M. Wick,et al.  Levodopa therapy and malignant melanoma. , 1978, JAMA.

[269]  W. McCarthy,et al.  Endocrine influences on survival from malignant melanoma , 1978, Cancer.

[270]  N. Cascinelli,et al.  Stage I Melanoma of the Limbs: Assessment of Prognosis by Levels of Invasion and Maximum Thickness , 1978, Tumori.

[271]  O. Braun-falco,et al.  Prognostic index in malignant melanoma. , 1978, Archives of dermatology.

[272]  W. Clark,et al.  Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. , 1978, Archives of dermatology.

[273]  N. Davis.  MALIGNANT MELANOMA IN QUEENSLAND A REVIEW , 1978, The Australasian journal of dermatology.

[274]  A. Breslow,et al.  EVALUATION OF PROGNOSIS IN STAGE I CUTANEOUS MELANOMA , 1978, Plastic and reconstructive surgery.

[275]  F. Sim,et al.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results , 1978, Cancer.

[276]  V. Beral,et al.  Malignant melanoma and oral contraceptive use among women in California. , 1977, British Journal of Cancer.

[277]  S. Rosenberg,et al.  Prognostic Factors in Patients Undergoing Lymphadenectomy of Malignant Melanoma , 1977, Annals of surgery.

[278]  N. Cascinelli,et al.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. , 1977, The New England journal of medicine.

[279]  G. Beardmore.  PRIMARY CUTANEOUS POLYPOIDAL NON‐STAGEABLE MELANOMAS IN QUEENSLAND * † , 1977 .

[280]  M. Wick,et al.  L-dopa: selective toxicity for melanoma cells in vitro. , 1977, Science.

[281]  J. Woodruff,et al.  Biostatistical basis of elective node dissection for malignant melanoma. , 1977, Annals of surgery.

[282]  P. Hersey,et al.  PREVIOUS PREGNANCY AS A PROTECTIVE FACTOR AGAINST DEATH FROM MELANOMA , 1977, The Lancet.

[283]  A. Kopf,et al.  Familial malignant melanoma. , 1976, Cutis.

[284]  J. Fortner,et al.  Adverse effect of pregnancy on melanoma. A reappraisal , 1976, Cancer.

[285]  J. Nordlund.  Clinical appearance of cutaneous melanomas. , 1975, The Yale journal of biology and medicine.

[286]  A. Breslow.  Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma , 1975, Annals of surgery.

[287]  D. Page,et al.  CUTANEOUS MELANOMA: A TWENTY‐YEAR RETROSPECTIVE STUDY WITH CLINICOPATHOLOGIC CORRELATION , 1975, Plastic and reconstructive surgery.

[288]  W. Clark,et al.  The clinical diagnosis of malignant melanoma. , 1975, Seminars in oncology.

[289]  H. Wanebo,et al.  Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) , 1975, Cancer.

[290]  E. Strong,et al.  Prognostic factors in cutaneous melanoma of the head and neck. , 1973, The American journal of pathology.

[291]  E. Strong,et al.  Clinicopathologic study of cutaneous melanoma of the head and neck. , 1972, American journal of surgery.

[292]  A. Cochran,et al.  Assessment of prognosis in patients with malignant melanoma. , 1972, Lancet.

[293]  J. H. Little,et al.  RESULTS OF TREATMENT OF 361 PATIENTS WITH MALIGNANT MELANOMA IN QUEENSLAND , 1971, The Medical journal of Australia.

[294]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.

[295]  J. Shah,et al.  Prognostic significance of lymph node dissection in the treatment of malignant melanoma , 1970, Cancer.

[296]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[297]  M. Roberts,et al.  Malignant melanoma of the skin: prognostic value of histology in 89 cases. , 1968, British Journal of Cancer.

[298]  H. Johnson.  ABDOMINAL PAIN OF SPINAL ORIGIN , 1965, The Lancet.

[299]  Pack Gt.  End results in the treatment of malignant melanoma; a later report. , 1959 .

[300]  M. Kripke.  Immunology and photocarcinogenesis. New light on an old problem. , 1986, Journal of the American Academy of Dermatology.

[301]  D. Ellis,et al.  Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. , 1986, Journal of the American Academy of Dermatology.

[302]  T. Wade,et al.  The histology of malignant melanoma. , 1986, The Medical clinics of North America.

[303]  C. Balch,et al.  PROGNOSTIC HISTOPATHOLOGICAL FACTORS IN MALIGNANT MELANOMA , 1985, Pathology.

[304]  R. Lew,et al.  Adjuvant therapy of cutaneous malignant melanoma: a critical review. , 1985, Medical and pediatric oncology.

[305]  P. Heenan.  Cutaneous malignant melanoma in western Australia. , 1985, Pathology.

[306]  R. Sagebiel.  DIAGNOSIS AND MANAGEMENT OF PREMALIGNANT MELANOCYTIC PROLIFERATIONS , 1985, Pathology.

[307]  N. Cascinelli,et al.  Margins of of resection of malignant melanomas that are less than the hitherto conventional "wide and deep" margins are not advisable as yet. , 1985, The American Journal of dermatopathology.

[308]  R J Reed,et al.  THE HISTOLOGICAL VARIANCE OF MALIGNANT MELANOMA: THE INTERRELATIONSHIP OF HISTOLOGICAL SUBTYPE, NEOPLASTIC PROGRESSION, AND BIOLOGICAL BEHAVIOUR , 1985, Pathology.

[309]  D. Ellis,et al.  Estrogen and progesterone receptors in primary cutaneous melanoma. , 1985, The Journal of dermatologic surgery and oncology.

[310]  M. Stukonis,et al.  CONTRASTING INCIDENCES ALONG WITH DESCRIPTIVE MARKERS IN THE EPIDEMIOLOGY OF MELANOMA , 1985, Pathology.

[311]  P. Hersey.  Review of melanoma antigens recognized by monoclonal antibodies (MAbs). Their functional significance and applications in diagnosis and treatment of melanoma. , 1985, Pathology.

[312]  M. S. Blois,et al.  The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. , 1985, Journal of psychosomatic research.

[313]  B. Ackerman.  MALIGNANT MELANOMA IN SITU: THE FLAT, CURABLE STAGE OF MALIGNANT MELANOMA , 1985, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[314]  A. Ackerman.  No one should die of malignant melanoma. , 1985, Journal of the American Academy of Dermatology.

[315]  K. Søndergaard.  BIOLOGICAL BEHAVIOUR OF CUTANEOUS MALIGNANT MELANOMAS , 1985, Pathology.

[316]  R. Rangayyan,et al.  Nevoscopy: Three-Dimensional Computed Tomography of Nevi and Melanomas in Situ by Transillumination , 1984, IEEE Transactions on Medical Imaging.

[317]  M. Greene.  Dysplastic nevus syndrome. , 1984, Hospital practice.

[318]  N. Cascinelli,et al.  Long Term Results of Randomized Trial Comparing Immediate Versus Delayed Node Dissection in Stage I Melanoma of the Limbs , 1984 .

[319]  J. Sánchez,et al.  Melanomas of volar and subungual skin in Puerto Ricans. A clinicopathologic study. , 1984, Journal of the American Academy of Dermatology.

[320]  R. Lew,et al.  Malignant melanoma prognostic factors 4: ulceration width. , 1984, The Journal of dermatologic surgery and oncology.

[321]  B K Armstrong,et al.  Melanoma of the skin. , 1984, British medical bulletin.

[322]  A. Sober.  Prognostic Factors for Cutaneous Melanoma , 1984 .

[323]  J. Hermans,et al.  Incidence of Recurrence and Survival in Clinical Stage I Patients With Melanoma After Local Excision , 1984 .

[324]  R. Paladugu,et al.  Biologic behavior of thin malignant melanomas with regressive changes. , 1983, Archives of surgery.

[325]  P. Heenan,et al.  Survival from Invasive Cutaneous Malignant Melanoma in Western Australia and the Oxford Region: a Comparative Histological Study of High and Low Incidence Populations , 1983, Pathology.

[326]  T. Harris,et al.  Melanoma of the head and neck in Queensland. , 1983, Head & neck surgery.

[327]  J. Nordlund,et al.  Vitiligo: It Is Important , 1982 .

[328]  M. Mihm,et al.  A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. , 1982, Annals of surgery.

[329]  C. Damsky,et al.  Expression of Adhesion‐Related Membrane Components in Adherent Versus Nonadherent Hamster Melanoma Cells , 1982, Journal of cellular biochemistry.

[330]  T. Fitzpatrick.  Early recognition of primary cutaneous melanoma. , 1982, Hospital practice.

[331]  S. Ferrone,et al.  Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens. , 1982, Hybridoma.

[332]  J. Brown,et al.  Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group. , 1982, Hybridoma.

[333]  P. Natali,et al.  Malignant lentigo‐melanoma—A comparative histological and electron microscopy study , 1981, Journal of surgical oncology.

[334]  A. Nake,et al.  Increased frequency of multiple primary melanomas in hereditary familial melanoma. , 1981, Dermatologica.

[335]  V. Hearing.  Tumor-specific markers of malignant melanoma. , 1981, The American Journal of dermatopathology.

[336]  A J Dobson,et al.  TUMOUR THICKNESS AND HISTOLOGICAL TYPE IN MALIGNANT MELANOMA IN NEW SOUTH WALES, AUSTRALIA, 1970–76 , 1981, Pathology.

[337]  I M Ariel,et al.  Malignant melanoma of the upper extremities , 1981, Journal of surgical oncology.

[338]  M. Griffel,et al.  Survival of cutaneous malignant melanoma patients at university of lowa hospitals: 1950–1974 , 1981, Cancer.

[339]  H. E. Christensen,et al.  Biopsy and prognosis for cutaneous malignant melanomas in clinical stage I. , 1980, Scandinavian journal of plastic and reconstructive surgery.

[340]  R. Simmons,et al.  The value of preoperative screening procedures in stage I and II malignant melanoma , 1979, Journal of surgical oncology.

[341]  C. Balch,et al.  A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. , 1979, Surgery.

[342]  D. Roses,et al.  Malignant melanoma. Delayed hypersensitivity skin testing. , 1979, Archives of surgery.

[343]  R. Richart.  Letter: Identity of cervical dysplasias. , 1975, Lancet.

[344]  V. McGovern.  The Classification of Melanoma and its Relationship with Prognosis , 1970, Pathology.

[345]  G A Gellin,et al.  Malignant melanoma. A controlled study of possibly associated factors. , 1969, Archives of dermatology.